Cargando…
Choroidal Changes in Blood Flow in Patients with Intermediate AMD after Oral Dietary Supplement Based on Astaxanthin, Bromelain, Vitamin D3, Folic Acid, Lutein, and Antioxidants
Background and Objectives: The aim of this study was to investigate the impact of oral administration of the combination of astaxanthin (AXT), lutein, folic acid, vitamin D3, and bromelain with antioxidants on choroidal blood flow in patients with age-related intermediate macular degeneration (AMD)....
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412262/ https://www.ncbi.nlm.nih.gov/pubmed/36013559 http://dx.doi.org/10.3390/medicina58081092 |
_version_ | 1784775450676953088 |
---|---|
author | D’Aloisio, Rossella Di Antonio, Luca Toto, Lisa Rispoli, Marco Di Iorio, Angelo Delvecchio, Giancarlo Mastropasqua, Rodolfo |
author_facet | D’Aloisio, Rossella Di Antonio, Luca Toto, Lisa Rispoli, Marco Di Iorio, Angelo Delvecchio, Giancarlo Mastropasqua, Rodolfo |
author_sort | D’Aloisio, Rossella |
collection | PubMed |
description | Background and Objectives: The aim of this study was to investigate the impact of oral administration of the combination of astaxanthin (AXT), lutein, folic acid, vitamin D3, and bromelain with antioxidants on choroidal blood flow in patients with age-related intermediate macular degeneration (AMD). Materials and Methods: Patients affected by intermediate AMD and treated with daily oral nutritional supplement with AXT, bromelain, vitamin D3, folic acid, lutein, and antioxidants for a period of at least 6 months were included in this retrospective study. A control group homogenous for age and sex was also included in the analysis. All participants underwent a complete ophthalmologic examination, spectral domain optical coherence tomography (SD-OCT), and optical coherence tomography angiography (OCTA) evaluation. Outcome measures were choroidal thickness (CHT) and choriocapillary vessel density (CCVD) after six months of AXT assumption. Results: CCVD values showed statistically significant difference between cases and controls at baseline (p < 0.001) and in the cases during follow-up (p < 0.001). The CHT measurements showed statistically significant difference between cases and controls (p = 0.002) and in the cases during follow-up (p < 0.001). Conclusions: The combined use of structural OCT and OCTA allows for a detailed analysis in vivo of perfusion parameters of the choriocapillaris and choroid and evaluation of changes of choroidal blood flow after oral nutritional supplements that affect blood flow velocity. |
format | Online Article Text |
id | pubmed-9412262 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94122622022-08-27 Choroidal Changes in Blood Flow in Patients with Intermediate AMD after Oral Dietary Supplement Based on Astaxanthin, Bromelain, Vitamin D3, Folic Acid, Lutein, and Antioxidants D’Aloisio, Rossella Di Antonio, Luca Toto, Lisa Rispoli, Marco Di Iorio, Angelo Delvecchio, Giancarlo Mastropasqua, Rodolfo Medicina (Kaunas) Article Background and Objectives: The aim of this study was to investigate the impact of oral administration of the combination of astaxanthin (AXT), lutein, folic acid, vitamin D3, and bromelain with antioxidants on choroidal blood flow in patients with age-related intermediate macular degeneration (AMD). Materials and Methods: Patients affected by intermediate AMD and treated with daily oral nutritional supplement with AXT, bromelain, vitamin D3, folic acid, lutein, and antioxidants for a period of at least 6 months were included in this retrospective study. A control group homogenous for age and sex was also included in the analysis. All participants underwent a complete ophthalmologic examination, spectral domain optical coherence tomography (SD-OCT), and optical coherence tomography angiography (OCTA) evaluation. Outcome measures were choroidal thickness (CHT) and choriocapillary vessel density (CCVD) after six months of AXT assumption. Results: CCVD values showed statistically significant difference between cases and controls at baseline (p < 0.001) and in the cases during follow-up (p < 0.001). The CHT measurements showed statistically significant difference between cases and controls (p = 0.002) and in the cases during follow-up (p < 0.001). Conclusions: The combined use of structural OCT and OCTA allows for a detailed analysis in vivo of perfusion parameters of the choriocapillaris and choroid and evaluation of changes of choroidal blood flow after oral nutritional supplements that affect blood flow velocity. MDPI 2022-08-12 /pmc/articles/PMC9412262/ /pubmed/36013559 http://dx.doi.org/10.3390/medicina58081092 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article D’Aloisio, Rossella Di Antonio, Luca Toto, Lisa Rispoli, Marco Di Iorio, Angelo Delvecchio, Giancarlo Mastropasqua, Rodolfo Choroidal Changes in Blood Flow in Patients with Intermediate AMD after Oral Dietary Supplement Based on Astaxanthin, Bromelain, Vitamin D3, Folic Acid, Lutein, and Antioxidants |
title | Choroidal Changes in Blood Flow in Patients with Intermediate AMD after Oral Dietary Supplement Based on Astaxanthin, Bromelain, Vitamin D3, Folic Acid, Lutein, and Antioxidants |
title_full | Choroidal Changes in Blood Flow in Patients with Intermediate AMD after Oral Dietary Supplement Based on Astaxanthin, Bromelain, Vitamin D3, Folic Acid, Lutein, and Antioxidants |
title_fullStr | Choroidal Changes in Blood Flow in Patients with Intermediate AMD after Oral Dietary Supplement Based on Astaxanthin, Bromelain, Vitamin D3, Folic Acid, Lutein, and Antioxidants |
title_full_unstemmed | Choroidal Changes in Blood Flow in Patients with Intermediate AMD after Oral Dietary Supplement Based on Astaxanthin, Bromelain, Vitamin D3, Folic Acid, Lutein, and Antioxidants |
title_short | Choroidal Changes in Blood Flow in Patients with Intermediate AMD after Oral Dietary Supplement Based on Astaxanthin, Bromelain, Vitamin D3, Folic Acid, Lutein, and Antioxidants |
title_sort | choroidal changes in blood flow in patients with intermediate amd after oral dietary supplement based on astaxanthin, bromelain, vitamin d3, folic acid, lutein, and antioxidants |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412262/ https://www.ncbi.nlm.nih.gov/pubmed/36013559 http://dx.doi.org/10.3390/medicina58081092 |
work_keys_str_mv | AT daloisiorossella choroidalchangesinbloodflowinpatientswithintermediateamdafteroraldietarysupplementbasedonastaxanthinbromelainvitamind3folicacidluteinandantioxidants AT diantonioluca choroidalchangesinbloodflowinpatientswithintermediateamdafteroraldietarysupplementbasedonastaxanthinbromelainvitamind3folicacidluteinandantioxidants AT totolisa choroidalchangesinbloodflowinpatientswithintermediateamdafteroraldietarysupplementbasedonastaxanthinbromelainvitamind3folicacidluteinandantioxidants AT rispolimarco choroidalchangesinbloodflowinpatientswithintermediateamdafteroraldietarysupplementbasedonastaxanthinbromelainvitamind3folicacidluteinandantioxidants AT diiorioangelo choroidalchangesinbloodflowinpatientswithintermediateamdafteroraldietarysupplementbasedonastaxanthinbromelainvitamind3folicacidluteinandantioxidants AT delvecchiogiancarlo choroidalchangesinbloodflowinpatientswithintermediateamdafteroraldietarysupplementbasedonastaxanthinbromelainvitamind3folicacidluteinandantioxidants AT mastropasquarodolfo choroidalchangesinbloodflowinpatientswithintermediateamdafteroraldietarysupplementbasedonastaxanthinbromelainvitamind3folicacidluteinandantioxidants |